Morgan Stanley Call 120 CVS 20.12.../ DE000MB33TY9 /
28/10/2024 21:08:15 | Var.- | Denaro22:00:35 | Lettera22:00:35 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.011EUR | - | - Quantità in denaro: - |
- Quantità in lettera: - |
CVS HEALTH CORP. D... | 120.00 - | 20/12/2024 | Call |
GlobeNewswire
08/08
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
30/07
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Comme...
GlobeNewswire
11/04
Sharecare teams up with Anthem Blue Cross and Blue Shield on Jump Shot for Health initiative to supp...
GlobeNewswire
09/11/2023
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
27/09/2023
Payback Time! Community Pharmacists Cheer Class Action Lawsuit Against PBMs to Recoup DIR Fees